In one analysis, 16% of men with no suspicious lesions on MRI had clinically significant prostate cancer identified after ...

Researchers conducted a post hoc, retrospective, cross-sectional analysis of 182 patients with recurrent prostate cancer ...

Prostate cancer imaging developed by university researchers has shown “extremely encouraging” results in its first clinical ...

Overall, PSMA-PET/CT detected distant metastasis in 84 of 182 cases (46%) that were negative by other types of imaging, ...

Men with negative mpMRI results avoiding biopsy did not have increased risk for clinically significant prostate cancer.

A new study has found that many cases of high-risk nonmetastatic hormone-sensitive prostate cancer may be more advanced than previously thought.

Prostate-specific membrane antigen-positron emission tomography (PSMA-PET) frequently detects metastatic disease missed by conventional imaging, investigators report.

Keck Medicine of USC is participating in a national, multisite clinical trial examining if a water vapor system that uses ...

A new study led by researchers at the UCLA Health Jonsson Comprehensive Cancer Center has found that many cases of high-risk nonmetastatic hormone-sensitive prostate cancer may be more advanced than ...

A growing array of pharmaceutical options has investigators trying to figure out which drugs and drug combinations are the ...

This advanced imaging technology plays a critical role in redefining how prostate cancer is staged. PSMA-PET imaging uses tiny amounts of radioactive "tracers," called radiotracers, that binds to ...